Swiss Longitudinal Cohort
The planned research project is a prospective population-based cohort study, similar to the well-known Framingham study in the United States. So far, there is no similar research project in Switzerland.
It is planned to examine of three Swiss municipalities. Recruitment in a first Swiss municipality (Lostallo/Cama GR) started 2014 and ended in 2019. Overall, 496 participants were recruited in this municipality. The five-year follow-up in this municipality started in 2019. It is planned to start recruitment in a second Swiss municipality (Uznach SG) in 2020.
The examinations embrace a broad spectrum of measurements (for details the investigators refer to the published study protocol).
研究概览
研究类型
注册 (预期的)
联系人和位置
学习联系方式
- 姓名:Paul Erne, MD
- 邮箱:paul.erne@erne-net.ch
研究联系人备份
- 姓名:Andreas W Schoenenberger, MD
- 邮箱:Andreas.Schoenenberger@insel.ch
学习地点
-
-
Graubünden
-
Cama、Graubünden、瑞士、CH-6557
- 招聘中
- Cama
-
接触:
- Franco Muggli, MD
- 邮箱:fmuggli@bluewin.ch
-
Lostallo、Graubünden、瑞士、CH-6558
- 招聘中
- Lostallo
-
接触:
- Franco Muggli, MD
- 邮箱:fmuggli@bluewin.ch
-
-
Saint Gallen
-
Uznach、Saint Gallen、瑞士、8730
- 招聘中
- Linth Hospital
-
接触:
- Pierre-Alexandre Krayenbühl, MD
- 电话号码:+41 (0)55 285 49 62
- 邮箱:pierre-alexandre.krayenbuehl@spital-linth.ch
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- Resident of Cama GR, Lostallo GR, or Uznach SG
- Age ≥6 years (no upper age limit), for voluntary blood sample ≥18 years
- Willing to participate in long-term study
- Written informed consent (in participants ≥6 years and <18 years signed by parents)
Exclusion Criteria:
- No exclusion criteria
学习计划
研究是如何设计的?
设计细节
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
---|---|
死亡
大体时间:10年
|
10年
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Cardiovascular events
大体时间:10 years
|
Cardiovascular events (i.e.
stroke, myocardial infarction) will be assessed using questionnaires and case records.
|
10 years
|
Heart function
大体时间:10 years
|
Heart function will be assessed using questionnaires for symptoms, clinical examination and measurement of electromechanical activation time.
|
10 years
|
Cognitive function
大体时间:10 years
|
Cognitive function will be assessed using validated instruments.
|
10 years
|
Kidney function
大体时间:10 years
|
Kidney function will be assessed using laboratory measurements.
|
10 years
|
Autonomy
大体时间:10 years
|
Autonomy wil be assessed using validated instruments.
|
10 years
|
Nursing home admission
大体时间:10 years
|
Nursing home admissions will be assessed using standardized questions.
|
10 years
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Changes in cardiovascular risk factors
大体时间:10 years
|
Cardiovascular risk factors will be assessed using validated measurements.
|
10 years
|
合作者和调查者
调查人员
- 学习椅:Paul Erne, MD、Hypertension Excellence Centre Lucerne
- 首席研究员:Andreas W Schoenenberger, MD、University Department of Geriatrics, University of Bern
- 首席研究员:Paolo Suter, MD、University of Zurich
- 首席研究员:Franco Muggli, MD、Swiss Society of Hypertension
- 首席研究员:Renate Schoenenberger, MD、Hypertension Excellence Centre Lucerne
- 首席研究员:Pierre-Alexandre Krayenbühl, MD、Linth Hospital
出版物和有用的链接
一般刊物
- Pusterla L, Radovanovic D, Muggli F, Erne P, Schoenenberger AW, Schoenenberger-Berzins R, Parati G, Suter P, Lava SAG, Gallino A, Bianchetti MG. Impact of Cardiovascular Risk Factors on Arterial Stiffness in a Countryside Area of Switzerland: Insights from the Swiss Longitudinal Cohort Study. Cardiol Ther. 2022 Dec;11(4):545-557. doi: 10.1007/s40119-022-00280-8. Epub 2022 Sep 24.
- Schoenenberger AW, Radovanovic D, Muggli F, Suter PM, Schoenenberger-Berzins R, Parati G, Bianchetti MG, Gallino A, Erne P. Prevalence of ideal cardiovascular health in a community-based population - results from the Swiss Longitudinal Cohort Study (SWICOS). Swiss Med Wkly. 2021 Sep 28;151:w30040. doi: 10.4414/smw.2021.w30040. eCollection 2021 Sep 27.
- Schoenenberger AW, Muggli F, Parati G, Gallino A, Ehret G, Suter PM, Schoenenberger-Berzins R, Resink TJ, Erne P. Protocol of the Swiss Longitudinal Cohort Study (SWICOS) in rural Switzerland. BMJ Open. 2016 Nov 28;6(11):e013280. doi: 10.1136/bmjopen-2016-013280.
研究记录日期
研究主要日期
学习开始
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- SNCTP 000000612
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.
无干预的临床试验
-
University of Illinois at ChicagoShirley Ryan AbilityLab; Oakland University; Access Living主动,不招人
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Northwestern University主动,不招人
-
Otsuka Pharmaceutical Factory, Inc.Celerion完全的